Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Wondering who needs long term care insurance at 55? Learn about the key factors that determine your need for coverage.
27,171 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
As Ranpak tackles 2025 earnings, investors watch for sustainable packaging demand, margin discipline, and cash flow r...
AI-driven demand for high-bandwidth memory is squeezing the global supply, raising costs for devices and testing Appl...
As KVHI gears up for the 2025 earnings call, investors should focus on revenue drivers, margins, and long-term strate...
SpaceX stock stumbled since its IPO has sparked questions about what comes next. By charting historical IPO patterns ...
HeartBeam heads into 2025 earnings with a mix of potential breakthroughs and headwinds. This guide explains what the ...
Geopolitical tensions in the Middle East have stirred oil markets and lifted energy stocks. Here’s how Occidental Pet...
Volatility kept markets unsettled this week. Advisers say the right move depends on timelines and cash needs, with ma...
BMO Capital Markets cuts Lithium Americas' price target to $4.50, citing 15% capex inflation at Thacker Pass and ongo...
FUTY has delivered 64% returns over five years while charging just 0.084% in fees, as the utility sector blends stead...
Tech optimism propelled the stock market today as inflation fears cooled and megacap tech names delivered. This snaps...
Ford stock has momentum, but the decision to buy isn’t straightforward. This article breaks down the case for and aga...